ATE231721T1 - Verwendung von tropolon derivate zur hemmung des inositmono phosphatase - Google Patents
Verwendung von tropolon derivate zur hemmung des inositmono phosphataseInfo
- Publication number
- ATE231721T1 ATE231721T1 AT96916132T AT96916132T ATE231721T1 AT E231721 T1 ATE231721 T1 AT E231721T1 AT 96916132 T AT96916132 T AT 96916132T AT 96916132 T AT96916132 T AT 96916132T AT E231721 T1 ATE231721 T1 AT E231721T1
- Authority
- AT
- Austria
- Prior art keywords
- inositemono
- phosphatase
- inhibit
- tropolone derivatives
- tropolone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95107936 | 1995-05-24 | ||
PCT/EP1996/002160 WO1996037197A1 (en) | 1995-05-24 | 1996-05-20 | Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE231721T1 true ATE231721T1 (de) | 2003-02-15 |
Family
ID=8219287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96916132T ATE231721T1 (de) | 1995-05-24 | 1996-05-20 | Verwendung von tropolon derivate zur hemmung des inositmono phosphatase |
Country Status (13)
Country | Link |
---|---|
US (1) | US5990160A (de) |
EP (1) | EP0828483B1 (de) |
JP (1) | JP4054061B2 (de) |
KR (2) | KR20040004513A (de) |
AT (1) | ATE231721T1 (de) |
AU (1) | AU698059B2 (de) |
CA (1) | CA2221771C (de) |
DE (1) | DE69626010T2 (de) |
DK (1) | DK0828483T3 (de) |
ES (1) | ES2186782T3 (de) |
PT (1) | PT828483E (de) |
SI (1) | SI0828483T1 (de) |
WO (1) | WO1996037197A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689342B1 (en) * | 2002-07-29 | 2004-02-10 | Warner-Lambert Company | Oral care compositions comprising tropolone compounds and essential oils and methods of using the same |
GB201102248D0 (en) | 2011-02-09 | 2011-03-23 | Isis Innovation | Treatment of bipolar disorder |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56147704A (en) * | 1980-04-07 | 1981-11-16 | Rowaale Keshohin Kk | Dermatological composition |
US4981980A (en) * | 1989-09-14 | 1991-01-01 | Merck & Co., Inc. | Drug for treating manic depression |
-
1996
- 1996-05-20 WO PCT/EP1996/002160 patent/WO1996037197A1/en active IP Right Grant
- 1996-05-20 KR KR10-2003-7009874A patent/KR20040004513A/ko not_active Application Discontinuation
- 1996-05-20 SI SI9630569T patent/SI0828483T1/xx unknown
- 1996-05-20 DE DE69626010T patent/DE69626010T2/de not_active Expired - Lifetime
- 1996-05-20 EP EP96916132A patent/EP0828483B1/de not_active Expired - Lifetime
- 1996-05-20 PT PT96916132T patent/PT828483E/pt unknown
- 1996-05-20 ES ES96916132T patent/ES2186782T3/es not_active Expired - Lifetime
- 1996-05-20 CA CA002221771A patent/CA2221771C/en not_active Expired - Lifetime
- 1996-05-20 JP JP53536896A patent/JP4054061B2/ja not_active Expired - Lifetime
- 1996-05-20 DK DK96916132T patent/DK0828483T3/da active
- 1996-05-20 AT AT96916132T patent/ATE231721T1/de active
- 1996-05-20 AU AU59000/96A patent/AU698059B2/en not_active Expired
- 1996-05-20 KR KR1019970708357A patent/KR100412753B1/ko not_active IP Right Cessation
-
1999
- 1999-05-14 US US09/312,733 patent/US5990160A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2186782T3 (es) | 2003-05-16 |
EP0828483B1 (de) | 2003-01-29 |
PT828483E (pt) | 2003-06-30 |
JPH11505817A (ja) | 1999-05-25 |
WO1996037197A1 (en) | 1996-11-28 |
KR100412753B1 (ko) | 2004-04-21 |
AU5900096A (en) | 1996-12-11 |
KR20040004513A (ko) | 2004-01-13 |
DK0828483T3 (da) | 2003-05-19 |
DE69626010T2 (de) | 2003-07-24 |
EP0828483A1 (de) | 1998-03-18 |
DE69626010D1 (de) | 2003-03-06 |
SI0828483T1 (en) | 2003-06-30 |
US5990160A (en) | 1999-11-23 |
JP4054061B2 (ja) | 2008-02-27 |
CA2221771A1 (en) | 1996-11-28 |
KR19990021882A (ko) | 1999-03-25 |
AU698059B2 (en) | 1998-10-22 |
CA2221771C (en) | 2007-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
BG102071A (en) | Minor molecule inhibitors of rotamase enzymic activity | |
DE69837295D1 (de) | Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1 | |
DE69728594D1 (de) | Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen | |
EA199900194A1 (ru) | Реминерализующая композиция | |
DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
MX9300777A (es) | Derivados aminoacetilmercapto novedosos utiles como inhibidores de la encefalinasa y la eca | |
PT871454E (pt) | Inibidores fosforosos que contem protease de cisteina e de serina | |
DE69333931D1 (de) | Verwendung von Krillenzymen zur Behandlung von Zahnbelag | |
BG99177A (en) | New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase | |
DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
DE69635114D1 (de) | Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids | |
WO1997008934A3 (en) | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors | |
ATE231721T1 (de) | Verwendung von tropolon derivate zur hemmung des inositmono phosphatase | |
ZA9711468B (en) | New use of comt inhibitors | |
ES2070134T3 (es) | Inhibidores de lisil oxidasa. | |
DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
DE69732784D1 (de) | Inhibierung von invasiver remodulierung | |
ATE255822T1 (de) | Verwendung von sauren natriumpolyphosphaten zur keimhemmung von schimmel und hefen | |
DE69901104D1 (de) | Verwendung von mikroorganismen extrakten in kosmetischen oder pharmazeutischen zusammensetzungen | |
NO984964L (no) | Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0828483 Country of ref document: EP |